124 related articles for article (PubMed ID: 27121912)
21. A comparison of pyrogen detection tests in the quality control of meningococcal conjugate vaccines: The applicability of the Monocyte Activation Test.
Fernandes Silva V; da Silva Guedes Junior D; da Silveira IA; Santos Almeida A; de Paiva Conte F; Fernandes Delgado I; Caldeira Silva C; França Presgrave OA; Antunes de Mattos K
Altern Lab Anim; 2018 Nov; 46(5):255-272. PubMed ID: 30488711
[TBL] [Abstract][Full Text] [Related]
22. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.
Kikkert R; de Groot ER; Aarden LA
J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276
[TBL] [Abstract][Full Text] [Related]
23. Application of a TLR overexpression cell model in pyrogen detection.
Han Q; Hu R; Li H; Lei Z; Zhang X; Yu X; Zhang Q; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Biotechnol Bioeng; 2019 Jun; 116(6):1269-1279. PubMed ID: 30684361
[TBL] [Abstract][Full Text] [Related]
24. Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccines.
Vipond C; Findlay L; Feavers I; Care R
ALTEX; 2016; 33(1):47-53. PubMed ID: 26626274
[TBL] [Abstract][Full Text] [Related]
25. Sensor macrophages derived from human induced pluripotent stem cells to assess pyrogenic contaminations in parenteral drugs.
Abdin SM; Mansel F; Hashtchin AR; Ackermann M; Hansen G; Becker B; Kick B; Pham N; Dietz H; Schaniel C; Martin U; Spreitzer I; Lachmann N
Biofabrication; 2024 May; 16(3):. PubMed ID: 38701770
[TBL] [Abstract][Full Text] [Related]
26. Pyrogen testing of lipidic parenterals with a novel in vitro test--application of the IPT based on cryopreserved human whole blood.
Schindler S; Rosenberg U; Schlote D; Panse K; Kempe A; Fennrich S; Hartung T
Pharmeur Sci Notes; 2006 Aug; 2006(1):1-7. PubMed ID: 17694639
[TBL] [Abstract][Full Text] [Related]
27. Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood.
Schindler S; von Aulock S; Daneshian M; Hartung T
ALTEX; 2009; 26(4):265-77. PubMed ID: 20383472
[TBL] [Abstract][Full Text] [Related]
28. Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes.
Poole S; Thorpe R; Meager A; Gearing AJ
Dev Biol Stand; 1988; 69():121-3. PubMed ID: 3265674
[TBL] [Abstract][Full Text] [Related]
29. More than 70 years of pyrogen detection: Current state and future perspectives.
Fennrich S; Hennig U; Toliashvili L; Schlensak C; Wendel HP; Stoppelkamp S
Altern Lab Anim; 2016 Jul; 44(3):239-53. PubMed ID: 27494624
[TBL] [Abstract][Full Text] [Related]
30. Pyrogen detection methods: comparison of bovine whole blood assay (bWBA) and monocyte activation test (MAT).
Wunderlich C; Schumacher S; Kietzmann M
BMC Pharmacol Toxicol; 2014 Sep; 15():50. PubMed ID: 25209100
[TBL] [Abstract][Full Text] [Related]
31. Studies on the mechanism of endogenous pyrogen production. III. Human blood monocytes.
Bodel P
J Exp Med; 1974 Oct; 140(4):954-65. PubMed ID: 4427091
[TBL] [Abstract][Full Text] [Related]
32. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products.
Kim JH; Jung K; Kim J; Lee J; Kim H; Song H; Han K; Park S; Ahn C; Kim CW
Biologicals; 2021 Jun; 71():20-30. PubMed ID: 33994086
[TBL] [Abstract][Full Text] [Related]
33. Altered monocyte and macrophage numbers in blood and organs of chickens injected i.v. with lipopolysaccharide.
Bowen OT; Dienglewicz RL; Wideman RF; Erf GF
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):200-10. PubMed ID: 19477023
[TBL] [Abstract][Full Text] [Related]
34. Performance of monocyte activation test supplemented with human serum compared to fetal bovine serum.
Molenaar-de Backer MWA; Gitz E; Dieker M; Doodeman P; Ten Brinke A
ALTEX; 2021; 38(2):307-315. PubMed ID: 33118606
[TBL] [Abstract][Full Text] [Related]
35. Cryopreservation of human monocytes for pharmacopeial monocyte activation test.
Koryakina A; Frey E; Bruegger P
J Immunol Methods; 2014 Mar; 405():181-91. PubMed ID: 24456627
[TBL] [Abstract][Full Text] [Related]
36. In vitro pyrogenicity of Gram-positive bacteria--validation of the kit using fresh human whole blood.
François C; Neveu J; Sauvaire D; Bonnet PA; Tissier MH
Pharmeur Sci Notes; 2006 Aug; 2006(1):17-21. PubMed ID: 17694641
[TBL] [Abstract][Full Text] [Related]
37. Pyrogen testing revisited on occasion of the 25th anniversary of the whole blood monocyte activation test.
Hartung T
ALTEX; 2021; 38(1):3-19. PubMed ID: 33452528
[TBL] [Abstract][Full Text] [Related]
38. International validation of novel pyrogen tests based on human monocytoid cells.
Hoffmann S; Peterbauer A; Schindler S; Fennrich S; Poole S; Mistry Y; Montag-Lessing T; Spreitzer I; Löschner B; van Aalderen M; Bos R; Gommer M; Nibbeling R; Werner-Felmayer G; Loitzl P; Jungi T; Brcic M; Brügger P; Frey E; Bowe G; Casado J; Coecke S; de Lange J; Mogster B; Naess LM; Aaberge IS; Wendel A; Hartung T
J Immunol Methods; 2005 Mar; 298(1-2):161-73. PubMed ID: 15847806
[TBL] [Abstract][Full Text] [Related]
39. The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report.
Cirefice G; Schütte K; Spreitzer I; Charton E; Shaid S; Viviani L; Rubbrecht M; Manou I
Biologicals; 2023 Nov; 84():101702. PubMed ID: 37643507
[TBL] [Abstract][Full Text] [Related]
40. The human whole blood pyrogen test - lessons learned in twenty years.
Hartung T
ALTEX; 2015; 32(2):79-100. PubMed ID: 25863033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
